Dr. Capriotti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
919 Conestoga Rd
Building Two, Suite 106
Bryn Mawr, PA 19010Phone+1 610-525-5028
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Dermatology, 2006 - 2009
- Albert Einstein Medical CenterInternship, Transitional Year, 2005 - 2006
- Drexel University College of MedicineClass of 2005
Certifications & Licensure
- PA State Medical License 2005 - 2024
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- ALC-919 For The Treatment Of Common Warts Start of enrollment: 2015 Apr 01
- A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum Start of enrollment: 2017 Feb 27
- A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients Start of enrollment: 2017 Oct 24
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsA randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.Kara Capriotti, Milan J. Anadkat, Jennifer N. Choi, Benjamin Kaffenberger, Beth N. McLellan
Investigational New Drugs. 2019-06-26 - 2 citationsTopical application of povidone-iodine/dimethylsulfoxide ophthalmic gel preparation in Dutch-Belted rabbits.Jesse Pelletier, John Devine, Kara Capriotti, Samuel B. Barone, Capriotti Joseph A
Cutaneous and Ocular Toxicology. 2019-03-22 - 11 citationsChemotherapy-associated paronychia treated with 2% povidone-iodine: a series of cases.Kara Capriotti, Capriotti Joseph A, Jesse Pelletier, Kevin Stewart
Cancer Management and Research. 2017-06-26
Press Mentions
- Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 for Chemotherapy-Associated ParonychiaOctober 3rd, 2018
- New Gel Effective in Treating Molluscum ContagiosumMarch 5th, 2017
Professional Memberships
- Fellow
- Fellow
External Links
- Veloce BioPharmahttp://velocebiopharma.com
- Halodinehttp://halodine.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: